Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma: Reply to D'Arco et al

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)665-668
Number of pages4
JournalBritish Journal of Haematology
Issue number4
Publication statusPublished - Nov 1 2015


  • ABVD
  • Dose intensity
  • Doxorubicin
  • Hodgkin lymphoma
  • Interim positron emission tomography

ASJC Scopus subject areas

  • Hematology

Cite this